Skip to main content

Table 5 Results of the tree pollen study

From: Early nonreactivity in the conjunctival provocation test predicts beneficial outcome of sublingual immunotherapy

 

Placebo

1000 UA

No reaction

Reaction

P

No reaction

Reaction

P

Mean

SD

Mean

SD

Mean

SD

Mean

SD

TCS 14

11.90

7.20

12.62

8.14

0.85

8.50

6.28

13.15

7.19

0.02

TCS 30

9.84

6.90

10.96

6.96

0.46

7.79

5.52

11.03

6.01

0.04

TCS 60

9.15

6.43

9.27

5.88

0.73

7.36

5.31

9.67

5.33

0.10

RTSS 14

7.10

3.11

6.96

4.16

0.75

4.64

2.78

6.72

3.47

0.02

RTSS 30

5.93

2.94

6.30

3.76

0.83

4.35

2.58

5.75

3.08

0.05

RTSS 60

5.55

2.54

5.49

3.03

0.90

3.94

2.40

5.17

2.66

0.07

TRMS 14

4.81

5.66

5.66

5.30

0.30

3.86

4.70

6.43

5.17

0.08

TRMS 30

3.91

5.16

4.66

4.52

0.26

3.44

4.19

5.29

4.38

0.10

TRMS 60

3.60

4.89

3.78

4.06

0.42

3.42

3.81

4.50

4.03

0.26

Well days

14.17

14.94

15.75

17.85

0.88

22.76

18.73

15.08

16.01

0.16

Efficacy

2.56

0.62

2.06

0.79

0.02

2.29

0.85

2.05

0.78

0.24

Satisfaction

2.11

0.90

1.97

0.85

0.49

2.18

0.81

1.92

1.01

0.42

Recommendation

2.17

0.79

2.33

0.86

0.32

2.41

0.71

2.15

0.93

0.36

  1. RTSS rhinoconjunctivitis total symptom score, SD standard deviation, TCS total combined score, TRMS total rescue medication score, UA unit of allergen
Back to article page

Clinical and Translational Allergy

ISSN: 2045-7022

Contact us